Observational studyActas urologicas espanolas2021
Impact of COVID-19 outbreak on urology surgical waiting lists and waiting lists prioritization strategies in the Post-COVID-19 era.
Observational study in Actas urologicas espanolas, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 21 citations in OpenAlex.
- Optimising prostate cancer pathways: Improving post-biopsy waiting times in a tertiary centre.BJUI compass · 2025Article
- Has cross-level clinical coordination changed in the context of the pandemic? The case of the Catalan health system.BMC health services research · 2024Article
- Assessment of the dynamics of inpatient health care delivery in Poland before and throughout the COVID-19 pandemic.Scientific reports · 2024Article
- COVID‑19‑related postponement of elective sexual or reproductive health operations deteriorates private and sexual life: an ongoing nightmare study.International journal of impotence research · 2022Article
- Changes in Access to Health Services during the COVID-19 Pandemic: A Scoping Review.International journal of environmental research and public health · 2022Article
- How the First Year of COVID-19 Affected Elective Pediatric Urology Patients: A Longitudinal Study Based on Waiting Lists and Surveys From 10 European Centers.Frontiers in public health · 2022Article
- Impact of COVID-19 on Surgical Volume: Single-Center Experience from Addis Ababa, Ethiopia.Ethiopian journal of health sciences · 2022Article
- COVID-19 and prostate cancer: a complex scenario with multiple facets.Future science OA · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe suspension of most elective surgeries during COVID-19 pandemic caused the lengthening of urology surgical waiting lists. The objective of this study is to evaluate the impact of COVID-19 pandemic on urology surgical waiting list in a high-volume hospital.
methodsAn observational descriptive study was designed. All patients included in the urology surgical waiting list of our high-volume center on May 1
resultsA total of 350 patients were included. The mean (SD) time on the waiting list was 97.33 (55.47) days. Priority 1 patients, who normally should undergo surgery within 30 days, were on the waiting list for a mean (SD) time of 60.51 (20.14) days. They were mainly patients with ureteral lithiasis (25.6%), high-risk or muscle-invasive bladder cancer (20.9%) and high-risk prostate cancer (13.9%). The mean waiting time had already significantly exceeded the mean time to surgery in 2019 for radical cystectomy (p = 0.04) and URS (p = 0.003).
conclusionsThe suspension of most elective surgeries due to COVID-19 had a significant impact on urology surgical waiting list of our high-volume center, especially in priority 1 group.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.